Aigerim Siu

Aigerim Siu currently serves as Clinical Study Lead at Xilio Therapeutics, Inc. since April 2022. Prior experience includes roles at GSK from January 2020 to April 2022 as US Delivery Lead (secondment) and Sr. Manager of Investigator Contracts, Benchmarking and Payments. Aigerim's tenure at TESARO, Inc. spanned from January 2015 to January 2020, where responsibilities included Sr. Manager of Clinical Operations and Analytics as well as Business Operations Manager. Additional experience includes Vendor Contracts Manager at PRA Health Sciences from June 2013 to December 2014 and Clinical Contracts Associate at Biogen from March 2011 to May 2013. Aigerim holds a Graduate Certificate in Clinical Research from Boston College and has a law education from University of Kyrgyzstan Law School.